|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
Re: thats John Banks who aksed the questions 
This stock has been doing this for just about forever.
Many of us expected the roller coaster to stop with
pancreatic imaging, but I for one did not read the
fine print. The test...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
5-Feb-10 09:25 pm |
| |
| 2. |
Re: Pound management on the call tom
It may be, but it appears we will know for sure before
the end of 2010.
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
4-Feb-10 08:39 am |
| |
| 3. |
Re: Pound management on the call tom
How do we ask a question that shows that management's
current path is all wrong. They have built an incredibly
strong cash position in a market where everyone indicates
cash is king. They...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
3-Feb-10 08:13 pm |
| |
| 4. |
The market continues to ingnore
RGEN's announcement today seems to guarantee protein
A income for the next 20 years or so (absent a paradigm
change in the production of monoclonal antibodies).
This year RGEN grosses around 11...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
3-Feb-10 10:32 am |
| |
| 5. |
Blackrock
Has now bought over 5.5 % of Rgen http://finance.aol.com/company/repligen-corporation/rgen/nas/SCH%2013G/10558331/html/sec-filings
and still the SP gets hammered
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
29-Jan-10 03:27 pm |
| |
| 6. |
Re: Cash $42.8M plus $15,919,000M long term
Yes, but RGEN makes over $20 million a year (and this
amount continues to increase yearly) 70%+ of which
is being spent on research, trials, etc. They'
;re...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
20-Jan-10 01:08 pm |
| |
| 7. |
Re: repligen investors with no participation?
There was little or no difference between the phase
2 and phase 3 results. In phase 2 the quotes were
"The study showed an improvement in sensitivity
of detection of structural...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
5-Jan-10 08:07 pm |
| |
| 8. |
Re: repligen investors with no participation?
As of last quarter's conference call, they had
enrolled 94 of 150 candidates and are predicting to
complete enrollment by mid 2010. Results would be
...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
30-Dec-09 02:50 pm |
| |
| 9. |
Re: repligen investors with no participation?
I think there is a fair amount of competition for any
firm that has something close to market (from medium,
big pharma). RGEN is not the only small firm with
lots of cash (see INSM insmed they have around 12
0...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
26-Dec-09 11:42 pm |
| |
| 10. |
Re: repligen investors with no participation?
There are only a few posters and most of them (us)
have been in the stock for many years. There are also
a few random posters, but they are universally...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
26-Dec-09 02:37 pm |
| |
| 11. |
Re: UNDERWATER ON RGEN never expected
Nothing is a slam dunk. The imaging stuff seemed great
because it was a repeat of the phase 2 test and in
fact the phase 3 test turned out better, but the fda
asked for...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
19-Dec-09 10:58 pm |
| |
| 12. |
Re: Give me one reason to buy now
This is a company with a solid base and a lot of upside.
At 30 million shares outstanding you should be able
to sell the furniture to get $4 a share (60 million
in cash, 6 years of...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
9-Dec-09 12:22 pm |
| |
| 13. |
Re: M & A activity end of year GREAT!
If the pancreatic imaging test results are successful
as expected in mid December then we should very quickly
see a partnership with some larger entity for...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation
|
|
mdpassinc |
|
8-Dec-09 09:49 am |
| |
| 14. |
Re: TRGT
Citalopram (Celexa) is an SSRI with all the known side
effects. TC5214 is a NNR (neuronal nicotinic receptor)
treatment. In the trial it was used to augment (i.e.
in addition to) the...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation (RGEN)
|
|
mdpassinc |
|
3-Dec-09 03:04 pm |
| |
| 15. |
An insider buy at $5
I wonder if this means he actually believes the stock
is going up soon? http://finance.aol.com/company/
repligen-corporation/rgen/nas/4/091190971/html/sec
-filings
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation (RGEN)
|
|
mdpassinc |
|
17-Nov-09 05:42 pm |
| |
| 16. |
Re: Secretin
Can you tell me where you got this quote? RGEN indicates
that it is not marketing anything, but its own Secretin
and seems to think it has the market to itself?
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation (RGEN)
|
|
mdpassinc |
|
5-Nov-09 10:18 am |
| |
| 17. |
Re: Orencia Sales
RGEN had a use patent for the drug, giving them the
exclusive right to use the drug for auto-immune diseases
such as arthritis and lupus. The patent for the drug
itself was lost...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation (RGEN)
|
|
mdpassinc |
|
23-Oct-09 12:32 pm |
| |
| 18. |
Another new direction - SMA
"Families of Spinal Muscular Atrophy Licenses
Potential Treatment for SMA to Repligen Corporation"
So now RGEN has Fredriechs Ataxia, SMA, Secretin imaging,
Bipolar depression, Huntingtons (not much...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation (RGEN)
|
|
mdpassinc |
|
22-Oct-09 04:28 pm |
| |
| 19. |
Re: Secretin
Took a look at the ChiRhoClin website and understand
the confusion. The only difference I can see is that
hey talk about porcine Secretin while RGEN talks about
human. RGEN used to market a product...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation (RGEN)
|
|
mdpassinc |
|
21-Oct-09 10:31 am |
| |
| 20. |
Re: Secretin
Don't recognize ChiRhoClin, but RGEN got into this
because Secretin was being used off label to help
with Pancreatic imaging. In order for practitioners
to get...
Business & Finance > Investments > Stocks (A to Z) > Stocks R >
Repligen Corporation (RGEN)
|
|
mdpassinc |
|
21-Oct-09 10:21 am |
| |